A Prospective Observational Registry of H.P. Acthar Gel for the Treatment of Multiple Sclerosis Relapse
Phase of Trial: Phase IV
Latest Information Update: 18 Jun 2018
At a glance
- Drugs Corticotropin (Primary) ; Corticotropin (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Mallinckrodt plc
- 18 Jun 2018 According to a Mallinckrodt plc media release, data from this trial was presented at the Annual Meeting of Consortium of Multiple Sclerosis Centers (CMSC 2018).
- 08 Jun 2018 Planned number of patients changed from 260 to 160.
- 01 Jun 2018 Results published in the Mallinckrodt plc Media Release